Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HIT It is the first and only potent, highly selective inhibitor of human 12-LOX in clinical ...

As it tried to demonstrate its continuing ability to fight, Ukraine said it had used drones to inflict serious damage on a Russian Kilo-class submarine at a Black Sea port. By Maria Varenikova ...

PONTE VEDRA, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of ...